Malignant neoplasm of breast
|
0.010 |
Biomarker
|
disease |
BEFREE |
We have experimentally verified the presence of a previously unknown IRA1/RGS17 fusion in the breast cancer cell line MCF7.
|
15326299 |
2004 |
Breast Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We have experimentally verified the presence of a previously unknown IRA1/RGS17 fusion in the breast cancer cell line MCF7.
|
15326299 |
2004 |
Amphetamine-Related Disorders
|
0.300 |
Biomarker
|
group |
CTD_human |
Genome-wide association for methamphetamine dependence: convergent results from 2 samples.
|
18316681 |
2008 |
Amphetamine Addiction
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genome-wide association for methamphetamine dependence: convergent results from 2 samples.
|
18316681 |
2008 |
Amphetamine Abuse
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genome-wide association for methamphetamine dependence: convergent results from 2 samples.
|
18316681 |
2008 |
Malignant neoplasm of lung
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
A region-wide scan across 6q23-25 found significant association between lung cancer susceptibility and three single nucleotide polymorphisms in the first intron of the RGS17 gene.
|
19351763 |
2009 |
Carcinoma of lung
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
A region-wide scan across 6q23-25 found significant association between lung cancer susceptibility and three single nucleotide polymorphisms in the first intron of the RGS17 gene.
|
19351763 |
2009 |
Primary malignant neoplasm of lung
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
A region-wide scan across 6q23-25 found significant association between lung cancer susceptibility and three single nucleotide polymorphisms in the first intron of the RGS17 gene.
|
19351763 |
2009 |
Lung Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Human lung tumor cell proliferation and tumorigenesis in nude mice are inhibited upon knockdown of RGS17 levels.
|
19351763 |
2009 |
Carcinogenesis
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
Human lung tumor cell proliferation and tumorigenesis in nude mice are inhibited upon knockdown of RGS17 levels.
|
19351763 |
2009 |
Prostatic Neoplasms
|
0.010 |
AlteredExpression
|
group |
LHGDN |
Through microarray and gene expression analysis, we show that expression of RGS17 is up-regulated in 80% of lung tumors, and also up-regulated in prostate tumors.
|
19244110 |
2009 |
Familial (FPAH)
|
0.010 |
Biomarker
|
disease |
BEFREE |
RGS17 is a major candidate for the familial lung cancer susceptibility locus on chromosome 6q23-25.
|
19351763 |
2009 |
Malignant neoplasm of lung
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Taken together, these data have provided the first evidence of miRNA regulation of RGS17 expression in lung cancer.
|
20420807 |
2010 |
Malignant neoplasm of lung
|
0.050 |
Biomarker
|
disease |
BEFREE |
Single nucleotide polymorphisms (SNP) on chromosomal regions 5p15.33, 6p21.33, 6q23-25/RGS17, and 15q24-25.1 were assessed for their associations with familial lung cancer.
|
20142248 |
2010 |
Carcinoma of lung
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
Taken together, these data have provided the first evidence of miRNA regulation of RGS17 expression in lung cancer.
|
20420807 |
2010 |
Carcinoma of lung
|
0.040 |
Biomarker
|
disease |
BEFREE |
Single nucleotide polymorphisms (SNP) on chromosomal regions 5p15.33, 6p21.33, 6q23-25/RGS17, and 15q24-25.1 were assessed for their associations with familial lung cancer.
|
20142248 |
2010 |
Primary malignant neoplasm of lung
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
Taken together, these data have provided the first evidence of miRNA regulation of RGS17 expression in lung cancer.
|
20420807 |
2010 |
Primary malignant neoplasm of lung
|
0.040 |
Biomarker
|
disease |
BEFREE |
Single nucleotide polymorphisms (SNP) on chromosomal regions 5p15.33, 6p21.33, 6q23-25/RGS17, and 15q24-25.1 were assessed for their associations with familial lung cancer.
|
20142248 |
2010 |
Lung Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
RGS17 is previously shown to be over-expressed in human lung adenocarcinomas and plays an important role in lung tumor growth.
|
20420807 |
2010 |
Adenocarcinoma of lung (disorder)
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RGS17 is previously shown to be over-expressed in human lung adenocarcinomas and plays an important role in lung tumor growth.
|
20420807 |
2010 |
Marijuana Abuse
|
0.310 |
Biomarker
|
disease |
PSYGENET |
The G allele of SNP rs596359, in the RGS17 promoter region, was associated with AD, CD, OD, or MjD in both populations (0.005≤P(empirical)≤0.019).
|
22591552 |
2012 |
Marijuana Abuse
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
The G allele of SNP rs596359, in the RGS17 promoter region, was associated with AD, CD, OD, or MjD in both populations (0.005≤P(empirical)≤0.019).
|
22591552 |
2012 |
Fasting blood glucose measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways.
|
22885924 |
2012 |
Fasting blood sugar result
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways.
|
22885924 |
2012 |
Substance Dependence
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The association of 13 RGS17 and eight RGS20 tag single nucleotide polymorphisms (SNPs) was examined with four substance dependence diagnoses (alcohol (AD), cocaine (CD), opioid (OD) or marijuana (MjD)] in 1,905 African Americans (AAs: 1,562 cases and 343 controls) and 1,332 European Americans (EAs: 981 cases and 351 controls).
|
22591552 |
2012 |